Mode
Text Size
Log in / Sign up

Peripheral ultrasound has low specificity for detecting subclinical coronary atherosclerosis in familial hypercholesterolemiaUltrasound May Help Identify Heart Risks in Specific Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that peripheral ultrasound has low specificity (32.0%) and is not a replacement for cardiac computed tomography.

This meta-analysis evaluates the diagnostic accuracy of carotid and femoral ultrasound compared to cardiac computed tomography for detecting subclinical coronary atherosclerosis in adults with familial hypercholesterolemia who have no history or symptoms of atherosclerotic disease. The study synthesized data on the prevalence of carotid plaques (68.5%), femoral plaques (56.5%), and a composite measure of coronary artery disease (46.4%).

Regarding diagnostic performance, the meta-analysis reported a sensitivity of 78.9% for peripheral ultrasound, while the specificity was notably low at 32.0%. The authors note that the evidence quality is very low. Due to this low quality, the findings should be interpreted with caution.

Clinically, the authors suggest that while carotid and femoral ultrasound are unsuitable as replacement tests for cardiac computed tomography, they may potentially serve as a triage test for risk stratification. However, the low specificity limits their utility as a standalone diagnostic tool for identifying coronary artery disease in this population.

How this fits prior evidence

This meta-analysis addresses a gap in diagnostic modalities for familial hypercholesterolemia. While prior coverage discussed the role of PCSK9 inhibitors and lipid lowering therapy patterns in patients with familial hypercholesterolemia and ASCVD, this study focuses on the diagnostic accuracy of peripheral ultrasound as a triage tool for risk stratification in patients without symptoms of atherosclerotic disease.

Researchers looked at how well ultrasound of the carotid and femoral arteries can detect early signs of heart disease in adults with familial hypercholesterolemia. This specific group of patients has a genetic condition that affects cholesterol levels. The study compared these ultrasound tests to cardiac computed tomography, which is a more standard imaging method.

The results showed that while ultrasound can detect plaques in the carotid and femoral arteries, it is not a replacement for cardiac computed tomography. The evidence for these findings is currently considered to be of very low quality. This means the data is not yet strong enough to change standard medical practices.

Because the evidence is limited, these ultrasound tests should not be used instead of standard heart scans. However, they might eventually help doctors sort patients into different risk groups. Patients with this condition should talk to their doctor about which screening tests are best for their specific health needs.

What this means for you:
Ultrasound may help identify heart risks in some patients, but it cannot replace standard cardiac CT scans.

Common questions

Can ultrasound replace a heart CT scan?

No, the study indicates that carotid and femoral ultrasound are not suitable as replacements for cardiac computed tomography. While ultrasound can show the presence of plaques, it does not provide the same level of diagnostic information as a CT scan for these patients.

Who is this finding relevant for?

This finding specifically concerns adults with familial hypercholesterolemia who do not yet have symptoms of heart disease. It looks at how well ultrasound can detect subclinical coronary atherosclerosis in this specific group.

How reliable is the evidence for using ultrasound?

The evidence for using these ultrasound tests is currently considered to be of very low quality. Because the data is limited, these tests are not yet recommended as a standard replacement for other heart imaging methods.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedDec 2026
View Original Abstract ↓
BACKGROUND: Familial hypercholesterolemia is characterized by lifelong exposure to high cholesterol levels and premature atherosclerotic cardiovascular disease. Unequivocal atherosclerosis on imaging reclassifies patients from high to very high risk. OBJECTIVE: The aim of this systematic review is to evaluate the diagnostic accuracy of carotid ultrasound and femoral ultrasound compared to cardiac computed tomography, for detecting subclinical coronary atherosclerosis in adults with familial hypercholesterolemia with no history or symptoms of atherosclerotic disease. METHODS: Studies published in full length in English were identified through a bibliographic database search in eight databases and two trial registers supplemented with backward and forward citation (updated 14 August 2026). Studies were evaluated using the Quality Assessment of Diagnostic Accuracy Studies-2 tool and synthesized using a generalized linear mixed model. The protocol was registered on Open Science Framework, osf.io/89z4a. RESULTS: Thirteen studies were included in the systematic review and three studies in the meta-analysis. Pooled prevalence estimates were 68.5% [62.2;74.5] for carotid plaques, 56.5% [48.3;64.5%] for femoral plaques and a composite measure of coronary artery disease 46.4% [34.4;58.6]. Peripheral ultrasound demonstrated a high sensitivity of 78.9% [51.5;93.0] and low specificity of 32.0% [14.0;57.6]. CONCLUSIONS: A small amount of very low-quality evidence was identified highlighting the need for further studies to determine the best test-and-treat strategy for this patient group. The current evidence suggests that carotid and femoral ultrasound are unsuitable as replacement tests for cardiac computed tomography but could potentially play a role as triage test for risk stratification.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.